Peptide receptor radionuclide therapy (PRRT) with Y-90-DOTA(0),Tyr(3)-octreotide (Y-Oc) and In-111-DTPA(0)-octreotide (In-Oc): Comparison of tumor response and toxicity.
Valkema, R., Pauwels, S., Jamar, F., Kvols, L., Bakker, W., Smith, C., & Krenning, E. (2002). Peptide receptor radionuclide therapy (PRRT) with Y-90-DOTA(0),Tyr(3)-octreotide (Y-Oc) and In-111-DTPA(0)-octreotide (In-Oc): Comparison of tumor response and toxicity. The Journal of Nuclear Medicine, 43(5), 34P-34P. (Original work published 2002)